Global Cardiopulmonary Stress Testing Systems Market Driven by Increasing Prevalence of Coronary Artery Disease

Over the past few years, cardiopulmonary exercise testing (CPET) has been recognized as a vital clinical tool, used to assess exercise capacity in patients and predict various cardiac conditions. CPET provides the assessment of integrative exercise response including cardiovascular, pulmonary, and skeletal muscle systems. Since the developments in the technology, cardiopulmonary stress testing systems are being consistently used in many clinical applications.

Changes in the lifestyle, stressful life, and lack of exercise have led to the growing obese population. This has led to the growth of cardiac patients, which has, in turn, increased the acceptance of cardiopulmonary stress testing systems. Transparency Market Research (TMR), in its new report, states that the global cardiopulmonary stress testing systems market was valued at US$3.30 bn in 2014 and is predicted to reach US$6.67 bn by 2023, expected to progress at an 8.20% CAGR from 2015 to 2023.

TMR experts answer a few important questions based on the global cardiopulmonary stress testing systems, which the readers would like to know:

Q. How is obesity the most important driving factor for the global cardiopulmonary stress testing systems market?

The modern lifestyle and the increasing habit of eating junk food have led to significant growth of obese people. The increasing cases of obesity have led to the increase in cardiac disorders. Currently, North America records the highest number of obese people. However, the number of obese people is expected to increase in Asia Pacific in the years to come. The global rise in the obese people is expected to be the most important factor driving the global cardiopulmonary stress testing systems market.

Q. Will technology plan an important role in the development of the global market?

Yes, technology has helped towards the development of many industries, and the global cardiopulmonary stress testing systems market is not an exception. Technological advancements in cardiopulmonary stress testing systems have enhanced the functional parameters, which is likely to propel the global market. Key companies operating in the global cardiopulmonary stress testing systems market are aiming to adopt new technologies for the development of new systems.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530

Q. How will the global market be affected by the rising occurrence of cardiovascular diseases?

The occurrence of cardiovascular diseases is been increasing since the recent past, which has been one of the driving factors for the global market. As per the World Health Organization, the coronary artery disease accounts for 64% of the total global deaths occurring from cardiovascular conditions. This has thus been recognized as one of the primary causes of average quality of life for a majority of the global population.

It is always boosting to see researchers investing more towards the development of new products. Recently, a women’s special hospital in Boston showed interest in developing new cardiopulmonary stress testing systems.

With many leading players showing interest and efforts towards the development of new cardiopulmonary stress testing systems, the global market is expected to show promising growth opportunities across many regions. The presence of key equipment manufacturers of cardiopulmonary stress testing systems, the application of laws including the Affordable healthcare Act, and the high awareness among people are some of the factors expected to propel the global cardiopulmonary stress testing systems market in the near future.

Microfluidic Device Systems Market in North America to Grow at Striking 21.70% CAGR from 2013 to 2019

Transparency Market Research has recently published a new research report that evaluates the overall global microfluidic device systems market and provides a trajectory of the market. The research report, titled “Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” studies microfluidic devices system as an evolving scientific field that has myriad analytical applications and a huge commercial potential.

It is a multidisciplinary field that uses engineering, chemistry, physics, nanotechnology, biochemistry, and biotechnology with practical solutions that use low fluid volumes achieve automation, multiplexing, and high-throughput screening. These devices are used in areas of cell biology research, medicine, and protein crystallization. The primary goal of these devices is to bring in efficiency and improve treatments.

According to the research report, the global microfluidic device systems market was valued at US$1.5 bn in 2013 and is expected to reach US$5.2 bn by 2019, rising at a CAGR of 22.80% between 2013 and 2019. The key factor propelling the global microfluidic device systems market is the high demand for these systems in chip miniaturization, proteomics, and genomics. Furthermore, the growing demand from the point-of-care testing segment will also boost this market.

The global microfluidic device systems market has been segmented on the basis of material, industry, application, and geography. The materials available in this market are glass, silicon, and polymer. The industries using these systems are pharmaceuticals, medical devices, and in-vitro diagnostics. On the basis of application this market is segmented into point of care testing, pharmaceutical and life science research, drug delivery, analytical devices, clinical and veterinary diagnostics, and environment and industrial. Geographically, this market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

Of all the industries, the in-vitro diagnostics industry is the largest user of microfluidic device systems. This industrial segment was valued at US$949.6 mn in 2013 and is likely to reach US$3.3 bn in 2019, surging at a CAGR of 23.20% 2013 and 2019. Meanwhile, the medical devices segment will also play a vital role in the changing application dynamics of the global microfluidic device systems market.

Out of all the applications, the veterinary and clinical diagnostics held the largest share in the market. However, analysts predict that point of care testing segment will show a remarkable growth rate in the global microfluidic device systems market in the foreseeable future. The North America microfluidic device system market holds a dominant position as it was valued at US$644.5 mn in 2013 and is expected to reach US$2 bn in 2019, expanding at a CAGR of 21.70% from 2013 to 2019.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1561

Some of the key players in the global microfluidic device systems market are Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Bio-Rad Laboratories, Agilent Technologies, Fluidigm Corporation, Becton Dickinson and Company, and Johnson & Johnson. The research report profiles these players and provides a complete analysis of the competitive landscape of the overall market. Furthermore, the report also presents a fair case of regulatory framework governing the overall market. The research and development activities, branding ideas, business and marketing strategies, and strategic mergers and acquisitions of these players have also been mentioned in this extensive research report.

Advancements and Innovations Driving the Hospital Stretchers Market

A report, titled “Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” from Transparency Market Research (TMR) provides a 360-degree view of the market. According to the report, the global hospital stretchers market is projected to expand at a CAGR of 3.90% during the forecast period from 2013 to 2019.

In 2012, the global hospital stretchers market was estimated at US$1.3 bn and by 2019, the market is projected to be worth US$1.7 bn. The global hospital stretchers market is driven by the rising prevalence of chronic conditions. Furthermore, the expanding geriatric and obese populations will also propel the global hospital stretchers market. The global hospital stretchers market will also benefit from the growing number of hospital stays.

Moreover, the increasing number of day care surgeries will also drive the global hospital stretchers market. The global hospital stretchers market will also benefit from the increasing average lifespan of hospital stretchers, which ranges from 7 to 10 years, and the growing presence of refurbished equipment. On the other hand, the global hospital stretchers market will be hampered by the high cost of specialized stretchers.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1518

On the basis of product type, the global hospital stretchers market is divided into radiographic stretchers, bariatric stretchers, adjustable stretchers, fixed-height stretchers, and others. The bariatric stretchers segment is projected to expand swiftly during the forecast period at a CAGR of 5.90%. This segment is driven by the rising obese population. As obese patients need to be carried to hospitals and healthcare centers with ease, the demand for bariatric stretchers has increased significantly due to their ability to carry very heavy weights.

According to technology, the global hospital stretchers market is bifurcated into motorized and non-motorized hospital stretchers. Application-wise, the global hospital stretchers market is classified into radiology, pediatric surgery, day care surgery, emergencies, and intra-hospital transport.

By region, the global hospital stretchers market is divided into Asia Pacific, Europe, North America, and Rest of the World (RoW). North America dominates the global hospital stretchers market due to the presence of a lot of manufacturers in this region. Furthermore, this region benefits from the rise in the population affected with chronic diseases and this region’s cutting-edge medical infrastructure.

Nevertheless, it is Asia Pacific that is the most favorable market in the global hospital stretchers market, due to the expanding medical tourism sector in this region. The medical tourism market is expanding rapidly in countries such as India and Singapore.

The research study recommends that companies must focus on developing innovative and cost-effective hospital stretchers. Players in the global hospital stretchers market, particularly small-scale industries, will also benefit by expanding their product portfolio. Moreover, focusing on the emerging markets of Latin America and Asia Pacific will also benefit companies operating in the global hospital stretchers market. Some of the leading companies operating in the global hospital stretchers market are Stryker Corporation, Givas, Gendron, Fu Shun Hsing Technology, and Anetic Aid Limited.